embecta announces changes to Board of Directors
(NASDAQ:EMBC), PARSIPPANY, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that David J. Albritton, a member of the Board of Directors (the “Board”) of embecta, has resigned from the Board […]